Literature DB >> 21989472

Considerations when prescribing trimethoprim-sulfamethoxazole.

Joanne M-W Ho1, David N Juurlink.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21989472      PMCID: PMC3216436          DOI: 10.1503/cmaj.111152

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  67 in total

1.  Impact of administrative restrictions on antibiotic use and expenditure in Ontario: time series analysis.

Authors:  Deborah Marshall; Jacqueline Gough; Paul Grootendorst; Melanie Buitendyk; Barbara Jaszewski; Susan Simonyi; Farah Jivraj; Stuart Macleod
Journal:  J Health Serv Res Policy       Date:  2006-01

2.  Drug-drug interactions among elderly patients hospitalized for drug toxicity.

Authors:  David N Juurlink; Muhammad Mamdani; Alexander Kopp; Andreas Laupacis; Donald A Redelmeier
Journal:  JAMA       Date:  2003-04-02       Impact factor: 56.272

3.  The effect of organic acids on renal clearance of methotrexate in man.

Authors:  D G Liegler; E S Henderson; M A Hahn; V T Oliverio
Journal:  Clin Pharmacol Ther       Date:  1969 Nov-Dec       Impact factor: 6.875

4.  Symptomatic hypoglycemia associated with trimethoprim/sulfamethoxazole and repaglinide in a diabetic patient.

Authors:  Matthieu Roustit; Emeline Blondel; Céline Villier; Xavier Fonrose; Michel P Mallaret
Journal:  Ann Pharmacother       Date:  2010-03-02       Impact factor: 3.154

5.  Cholestatic hepatitis with severe systemic reactions induced by trimethoprim-sulfamethoxazole.

Authors:  G Kouklakis; A Mpoumponaris; P Zezos; J Moschos; A Koulaouzidis; A Nakos; A Pehlivanidis; M Iosiphidis; E Molyvas; N Nikolaidis
Journal:  Ann Hepatol       Date:  2007 Jan-Mar       Impact factor: 2.400

6.  Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole.

Authors:  R Alappan; M A Perazella; G K Buller
Journal:  Ann Intern Med       Date:  1996-02-01       Impact factor: 25.391

7.  The management of acute uncomplicated cystitis in adult women by family physicians in Canada.

Authors:  Warren J McIsaac; Preeti Prakash; Susan Ross
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-07       Impact factor: 2.471

8.  Trimethoprim-sulfamethoxazole-induced cholestatic hepatitis. Inadvertent rechallenge.

Authors:  P W Thies; W L Dull
Journal:  Arch Intern Med       Date:  1984-08

9.  The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects.

Authors:  Mikko Niemi; Lauri I Kajosaari; Mikko Neuvonen; Janne T Backman; Pertti J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

Review 10.  Apparent hemolysis in an AIDS patient receiving trimethoprim/sulfamethoxazole: case report and literature review.

Authors:  C M Reinke; J K Thomas; A H Graves
Journal:  J Pharm Technol       Date:  1995 Nov-Dec
View more
  48 in total

1.  Coadministration of co-trimoxazole with sulfonylureas: hypoglycemia events and pattern of use.

Authors:  Alai Tan; Holly M Holmes; Yong-Fang Kuo; Mukaila A Raji; James S Goodwin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05-24       Impact factor: 6.053

Review 2.  Treatment of acne vulgaris during pregnancy and lactation.

Authors:  Y L Kong; H L Tey
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

3.  Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression.

Authors:  Thomas G Cotter; Nicola Gathaiya; Jelena Catania; Edward V Loftus; William J Tremaine; Larry M Baddour; W Scott Harmsen; Alan R Zinsmeister; William J Sandborn; Andrew H Limper; Darrell S Pardi
Journal:  Clin Gastroenterol Hepatol       Date:  2016-12-21       Impact factor: 11.382

4.  D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis.

Authors:  Stacy M Lenger; Megan S Bradley; Debbie A Thomas; Marnie H Bertolet; Jerry L Lowder; Siobhan Sutcliffe
Journal:  Am J Obstet Gynecol       Date:  2020-06-01       Impact factor: 8.661

5.  A decade of outpatient antimicrobial use in older adults in Ontario: a descriptive study.

Authors:  Charlie Tan; Erin Graves; Hong Lu; Anna Chen; Shudong Li; Kevin L Schwartz; Nick Daneman
Journal:  CMAJ Open       Date:  2017-12-21

6.  Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections.

Authors:  Loren G Miller; Robert S Daum; C Buddy Creech; David Young; Michele D Downing; Samantha J Eells; Stephanie Pettibone; Rebecca J Hoagland; Henry F Chambers
Journal:  N Engl J Med       Date:  2015-03-19       Impact factor: 91.245

7.  HPLC Plasma Assay of a Novel Anti-MRSA Compound, Kaempferol-3-O-Alpha-L-(2",3"-di-p-coumaroyl)rhamnoside, from Sycamore Leaves.

Authors:  Yiguan Zhang; Frederick Valeriote; Kenneth Swartz; Ben Chen; Mark T Hamann; Douglas L Rodenburg; James D McChesney; Jiajiu Shaw
Journal:  Nat Prod Commun       Date:  2015-08       Impact factor: 0.986

8.  Integron-Associated DfrB4, a Previously Uncharacterized Member of the Trimethoprim-Resistant Dihydrofolate Reductase B Family, Is a Clinically Identified Emergent Source of Antibiotic Resistance.

Authors:  Jacynthe L Toulouse; Thaddeus J Edens; Lorea Alejaldre; Amee R Manges; Joelle N Pelletier
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

9.  A Trimethoprim Conjugate of Thiomaltose Has Enhanced Antibacterial Efficacy In Vivo.

Authors:  Xiaojian Wang; Clarissa A Borges; Xinghai Ning; Mohammad Rafi; Jingtuo Zhang; Bora Park; Kiyoko Takemiya; Carlo Lo Sterzo; W Robert Taylor; Lee Riley; Niren Murthy
Journal:  Bioconjug Chem       Date:  2018-04-25       Impact factor: 4.774

Review 10.  Cotrimoxazole and neonatal kernicterus: a review.

Authors:  Baskaran Thyagarajan; Sharad S Deshpande
Journal:  Drug Chem Toxicol       Date:  2013-10-07       Impact factor: 3.356

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.